OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Organ Transplantation is 6. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Delayed graft function: current status and future directions	70
Molecular matching tools for allocation and immunosuppression optimization. Ready for primetime?	42
Editorial: Organ Preservation Revolution: the future is revisiting the past through a different lens	28
Immunosuppression after uterus transplantation	24
HLA-DQ antibodies in alloimmunity, what makes them different?	23
The perspective for next-generation lung replacement therapies: functional whole lung generation by blastocyst complementation	22
Obesity and kidney transplantation	21
Editorial introductions	20
Update on surgical management of enteroatmospheric fistulae in intestinal failure patients	19
Overview of pregnancy in solid-organ transplantation	19
Using organ perfusion to optimize donor livers	19
Deceased donors with multidrug-resistant organisms: implications and future directions	16
New insights into ischemia-reperfusion injury signaling pathways in organ transplantation	16
Urine CXCL10 as a biomarker in kidney transplantation	16
What is needed to ensure long-term sustainability for the field of vascularized composite allotransplantation?	15
Modifying organs with gene therapy and gene modulation in the age of machine perfusion	14
Human cytomegalovirus: a survey of end-organ diseases and diagnostic challenges in solid organ transplant recipients	14
Editorial introductions	14
Equity in liver transplantation: are we any closer?	13
Kidney transplant outcomes in minority populations: can we close the gap?	13
The ethics of donation after circulatory death organ recovery: an overview of new considerations arising from procurement practice and policy changes	12
Role of T follicular helper and T follicular regulatory cells in antibody-mediated rejection: new therapeutic targets?	12
Integrating risks and benefits: pretransplant assessment and patient selection for heart transplantation in adult congenital heart disease	11
Update on combined heart and liver transplantation: evolving patient selection, improving outcomes, and outstanding questions	11
Respiratory viral infections including COVID-19 in solid organ transplantation	10

Establishing an upper extremity transplantation program: lessons learnt over 12 years	10
Geographic disparities in transplantation	10
Language and cultural concordance to promote equity in organ transplantation for Hispanics with limited English proficiency	9
Management of the sensitized heart transplant candidate	9
Regulatory dendritic cell therapy in organ transplantation	9
Uterus transplantation: the importance of uterine natural killer cells	9
Gender and racial disparities in the transplant surgery workforce	8
The sex disparity in liver transplantation	8
Novel agents in the treatment of invasive fungal infections in solid organ transplant recipients	8
Noninvasive methods to reduce cardiac complications postheart transplant	8
Donor-derived infections in solid organ transplant recipients	8
A cystic fibrosis patient	8
Cardiac evaluation of the liver transplant candidate	8
Elucidating measures of systemic racism to mitigate racial disparities in kidney transplantation	8
Microbiota in heart and lung transplantation: implications for innate-adaptive immune interface	8
Antispike monoclonal antibodies for prevention and treatment of coronavirus disease-2019 in solid organ transplant recipients	8
Beyond donation to organ utilization in the UK	8
Regulatory and transitional B cells: potential biomarkers and therapeutic targets in organ transplantation	8
A review of transplant infectious diseases and pediatric transplant infectious diseases curriculum	8
Machine perfusion in liver transplantation: recent advances and coming challenges	7
Defining chronic rejection in vascularized composite allografts – do we have reliable surrogates to look for?	7
Are split liver grafts a suitable option in high-risk liver transplant recipients?	7
Editorial: Uterus transplantation: the only curative treatment for absolute uterine factor infertility is moving forward	7
Future directions for xenotransplantation in lungs	7
Social support and transplantation	7
Chronic rejection as a persisting phantom menace in organ transplantation: a new hope in the microbiota?	7
Editorial: Disparities in transplantation access and outcomes: mind the gap!	7
Clinical and biomarker assessment of frailty in liver transplantation	7
Ethical issues in organ procurement: donation after normothermic regional perfusion in liver transplantation	7
Lung preservation: from perfusion to temperature	6
Ethical considerations in lung re-transplantation	6
Thoraco-abdominal normothermic regional perfusion for thoracic transplantation in the United States: current state and future directions	6
The role of living donor liver transplantation in colorectal cancer liver metastases	6
Nontransplant options for portomesenteric thrombosis	6
Management of long-term cardiovascular risk factors post organ transplant: Erratum	6
The road to xenotransplantation	6
Pediatric intestinal rehabilitation	6
Unraveling the spectrum of airway complications following lung transplantation: a comprehensive overview	6
Disparities in living donation	6
Living liver donor pain management	6
Editorial introductions	6
New insights into the microbiome in kidney transplantation	6
Liver transplantation for intrahepatic cholangiocarcinoma: who, when and how	6
Normothermic regional perfusion for donation after circulatory death donors	6
Social and biologic determinants in lung transplant allocation	6
Novel cell-based strategies for immunomodulation in vascularized composite allotransplantation	6
Grasping time – longevity of vascularized composite allografts	6